Team:EPF Lausanne/Calendar/1 August 2013

From 2013.igem.org

(Difference between revisions)
Line 2: Line 2:
'''Cell Surface Display'''
'''Cell Surface Display'''
-
''Gibson Assembly: ''  
+
''Gibson Assembly ''  
-
<br> We did the DpnI digestion of our previous PCR products (streptavidin dead and INP_construct) to remove any carry over of the original plasmids.
+
<br> -We did the DpnI digestion of our previous PCR products (streptavidin dead and INP_construct) to remove any carry over of the original plasmids.
-
<br>Gibson Assembly from the DpnI digested products (see under protocols).
+
<br>-Gibson Assembly from the DpnI digested products (see under protocols).
-
<br> Gel electrophoresis to verify the Gibson product.
+
<br> -Gel electrophoresis to verify the Gibson product.
-
'''Nanoparticles'''
+
'''Nanoparticles''' <BR>
-
Make nanoparticles: try 1 (second cross-linking step with glutaraldehyde of the GPs+dye).  
+
''Making nanoparticles 1st try'' <br>
 +
We did the second cross-linking step with glutaraldehyde of the GPs+dye.  
{{Template:EPFL2013Footer}}
{{Template:EPFL2013Footer}}

Revision as of 14:36, 3 October 2013

Taxi.Coli: Smart Drug Delivery iGEM EPFL

Header

Cell Surface Display

Gibson Assembly
-We did the DpnI digestion of our previous PCR products (streptavidin dead and INP_construct) to remove any carry over of the original plasmids.
-Gibson Assembly from the DpnI digested products (see under protocols).
-Gel electrophoresis to verify the Gibson product.

Nanoparticles

Making nanoparticles 1st try
We did the second cross-linking step with glutaraldehyde of the GPs+dye.